Dr med Kokularajah Paheenthararajah

He/himCounsel

Extremely hardworking, his dual qualifications allow him a depth of knowledge and understanding rarely seen anywhere else.

— Legal 500 Germany 2022

Emailkokularajah.paheenthararajah@dlapiper.com

Call+49 221 277 277 307

Cologne

About

Areas of FocusLife Sciences Technology

EXPERIENCE

Advising and representing a global pharmaceutical company in the EU-wide enforcement of its second medical use patent for a blockbuster drug for the treatment of neuropathic pain and epilepsy.
Advising a global pharmaceutical company on supplementary protection certificates (SPCs) as well as regulatory data and market exclusivity requirements in connection with its novel antiretroviral active substance for the treatment of HIV/AIDS.
Advising a global pharmaceutical company on the experimental use privilege (Roche-Bolar exemption) and orphan drug regulations in connection with Phase-III clinical trials on a novel bi-specific monoclonal antibody for the treatment of a hematologic disease.
Advising and representing a global pharmaceutical company on a patent relating to a PD-1 inhibitor (monoclonal antibody) for the immunotherapy of cancers.
Advising and representing a client on patent and licensing disputes relating to an innovative biotechnology for the production of a recombinant blockbuster drug for the treatment of hemophilia-A.
Advising a leading US biotechnology company on patent and licensing issues in connection with the R&D of a novel gene therapy for the treatment of an orphan hereditary lysosomal storage disease (orphan drug).
Advising and representing a global diagnostics company in enforcing its patent relating to DNA amplification and sequencing (next generation sequencing).
Advising a leading biotechnology company on regulatory issues relating to drug pricing, market access, prescription and substitution requirements as well as licensing and marketing strategies for a novel gene therapy for the treatment of chronic lymphocytic leukemia (CLL) and multiple sclerosis (MS).
Advising a global diagnostics company on complex regulatory and strategic issues relating to R&D, reimbursement, prescription, advertisement, marketing, healthcare compliance and digital health marketing requirements regarding its innovative real-time continuous glucose monitoring (rtCGM) system for diabetes patients.
Advising a leading US pharmaceutical company on the R&D of an autologous cellular immunotherapy (TIL) for personalized treatment of metastatic melanoma and cervical carcinoma, including regulatory tissue establishment and procurement licenses requirements and licenses for manufacturing, importing and exporting human tissues and advanced therapy medicinal products (ATMPs) for clinical trial purposes.

Languages

Education

University of Cologne, Ph. D. (Medicine), 2014

Higher Regional Court of Cologne, Second State Examination (Law), 2014

University Hospital Cologne / University of Cologne, Second State Examination (Medicine), 2012

University of Cologne, First State Examination (Medicine), 2008

University of Cologne, First State Examination (Law), 2006

Awards

Legal 500 Germany 2022: Recommended for intellectual property: patent litigation; “Extremely hardworking, his dual qualifications allow him a depth of knowledge and understanding rarely seen anywhere else.”
Handelsblatt in cooperation with Best Lawyers 2023: Recommended for intellectual property law
Managing Intellectual Property (MIP) – IP Stars 2020/2021: Recommended for IP/patent litigation
Managing Intellectual Property (MIP) – Rising Stars 2019/2020: “Rising Star” IP/patent litigation

Publications

Prior Experience

Prior to joining the Cologne office of DLA Piper in October 2017, Kokularajah worked as a lawyer at a leading international patent litigation and life sciences practice of a Magic Circle law firm in Munich (2014-2017). Before that, he worked as a legal assistant at the litigation and life sciences practice of another Magic Circle law firm (2006-2014).

Life Sciences Know-how

Kokularajah received additional medical training for physicians, inter alia, at the University Hospital Cologne, King’s College London/Cicely Saunders Institute of Palliative Care and St. John’s Medical College Bangalore. For his medical doctoral thesis Kokularajah received the 2016 Doctoral Dissertation Award of the Medical Faculty of the University of Cologne.

Kokularajah is admitted as a physician (Arzt) with the District Government of Cologne (Bezirksregierung) and is a member of the Medical Association of North Rhine (Ärztekammer Nordrhein).